Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CAR-T Update: Kite's Filing Coming Soon

Executive Summary

With all eyes on the race to get the autologous cell immunotherapies to market, Kite announces it could soon see late-stage data on its lead candidate.

Advertisement

Related Content

New Interim CAR-T Data Support Kite’s BLA Submission Plans
INTERVIEW: Juno CEO Hans Bishop On The CAR-T Learning Curve
Juno, Kite Stand By Their Products As Novartis's Shift Renews CAR-T Concerns
Tech Transfer Deals, July 2016: Kite Moves Toward Off-The-Shelf T-Cell Therapy
Don't Panic! Novartis Is Still Invested In CAR-T Despite 2Q Silence
Juno ROCKETs On Fast Clinical Hold Resolution

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC097090

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel